Access to new medicines in the English NHS

This briefing describes processes that decide whether NHS services in England will pay for patients to receive new, patented drugs, from the initial development& testing of drugs, to NICE ' s appraisal of their effectiveness and negotiations between NHS and Pharma to agree prices.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news